Condition: Membranous Nephropathy · Sponsor: Centre Hospitalier Universitaire de Nice
National cohort of all cases of membranous nephropathy (MN) during a 1 year period in France, based on a pathological and/or serological diagnostic, collecting the data on: * incidence of MN * prevalence of anti-PLA2R1 and anti-THSD7A * clinical outcome one year after diagnosis or after relapse (complete remission, partial remission or persistent nephrotic syndrome) * environmental risk factors for the onset of MN * HLA markers * patient care status in France
This description comes directly from the study's public registry record.
Barbara SEITZ-POLSKI, MD · +33 4 92 03 55 02 · seitz-polski.b@chu-nice.fr
Always discuss trial participation with your own doctor first.
| CHU de Nice, Hôpital de l'Archet | Nice, Alpes Maritime, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04326218